SAMINA QAMAR

Allopathic & Osteopathic Physicians|Family Medicine LODI, CA NPI 1720006067

General Payments — all program years on this page

$2,332.46

  • Category: General Payments
  • Program years: PY2018–2020
  • Record count: 175
  • As of (CMS publication): 2026-01-23

Latest program year (PY2020): $366.73 across 21 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2020) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $366.7321

By paying entity

Latest program year (PY2020) · sorted by reported total.

By program year

Program yearAmountRecords
2018 $963.3280
2019 $1,002.4174
2020 $366.7321

Records — PY2020 (21)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
716725509 Kowa Pharmaceuticals America, Inc. $12.23 04/16/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
716734415 Kowa Pharmaceuticals America, Inc. $16.26 07/09/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
716739163 Kowa Pharmaceuticals America, Inc. $15.70 08/14/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
719402597 Janssen Pharmaceuticals, Inc $16.83 02/11/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
719402599 Janssen Pharmaceuticals, Inc $15.00 01/21/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
719402601 Janssen Pharmaceuticals, Inc $16.67 08/10/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
719402603 Janssen Pharmaceuticals, Inc $12.24 08/18/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
719402605 Janssen Pharmaceuticals, Inc $21.90 07/06/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
720994253 Boehringer Ingelheim Pharmaceuticals, Inc. $20.17 03/02/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
726088717 Novartis Pharmaceuticals Corporation $19.86 01/30/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
727891909 E.R. Squibb & Sons, L.L.C. $17.10 01/31/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
728641065 Lilly USA, LLC $14.40 03/03/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
736115543 AstraZeneca Pharmaceuticals LP $12.97 03/02/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
736176625 AstraZeneca Pharmaceuticals LP $13.83 01/28/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
736273183 AstraZeneca Pharmaceuticals LP $24.10 02/29/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
743620065 PFIZER INC. $13.98 02/18/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
743622851 PFIZER INC. $33.78 06/22/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
743645469 PFIZER INC. $18.69 01/27/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
744641881 Novo Nordisk Inc $21.18 03/02/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
747642627 Merck Sharp & Dohme Corporation $14.55 07/27/2020 Food and Beverage Undisputed 01/23/2026 View at CMS
747666453 Merck Sharp & Dohme Corporation $15.29 03/09/2020 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2020_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.